Order Article Reprints

Isca C, Piacentini F, Mastrolia I, Masciale V, Caggia F, Toss A, Piombino C, Moscetti L, Barbolini M, Maur M, et al. Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature. Cancers. 2021; 13(19):4894. https://doi.org/10.3390/cancers13194894

Isca, Chrystel, Federico Piacentini, Ilenia Mastrolia, Valentina Masciale, Federica Caggia, Angela Toss, Claudia Piombino, Luca Moscetti, Monica Barbolini, Michela Maur, and et al. 2021. "Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature" Cancers 13, no. 19: 4894. https://doi.org/10.3390/cancers13194894

Isca, C., Piacentini, F., Mastrolia, I., Masciale, V., Caggia, F., Toss, A., Piombino, C., Moscetti, L., Barbolini, M., Maur, M., Dominici, M., & Omarini, C. (2021). Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature. Cancers, 13(19), 4894. https://doi.org/10.3390/cancers13194894